Panagiotis Sarantis

48PUBLICATIONS
59CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jul 13, 2026
Enhanced anti-tumor effects of Imatinib and immune checkpoint inhibitors on gastrointestinal stromal tumor cells (GISTs): insights from monoculture and 3D co-culture models.

|Jun 26, 2026
Microsatellite Phenotype as a Guide for Immunotherapy in Colorectal Cancer: Current Status and Future Perspectives.

|May 27, 2026
Regulatory T Cells in Hepatocellular Carcinoma: Spatial Niches, Biomarkers, and Clinical Implications.

|Mar 27, 2026
Advances in Extracellular Matrix Metalloproteinases: Implications for Renal Cell Carcinoma Pathophysiology, Diagnostics, and Therapeutics.

Evangelia Krikou, Ioanna A Anastasiou, Panagiotis Sarantis

|Feb 24, 2026
The Role of HER2 and RANK in Breast Cancer and New Therapeutic Approaches With Denosumab, Anti-HER2 Antibodies and Immunotherapy.

Panagiotis Sarantis, Aristofania Simatou, Ioanna A Anastasiou

|Feb 13, 2026
Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence.

Eleni Myrto Trifylli, Athanasios Angelakis, Sotirios P Fortis

Pageof 8

Frequent Collaborators

33 joint publications

Michalis V Karamouzis

15 joint publications

Nikolaos Garmpis

13 joint publications

Christos Damaskos

9 joint publications

Eleni-Myrto Trifylli